Refine
Document Type
- Article (11)
- Doctoral Thesis (1)
Language
- English (12)
Has Fulltext
- yes (12)
Is part of the Bibliography
- no (12)
Keywords
- neurodegeneration (3)
- PPARγ (2)
- nuclear receptor (2)
- polypharmacology (2)
- transcription factor (2)
- Anandamide (1)
- Biochemistry (1)
- Biophysical chemistry (1)
- CCL2 (1)
- Chemical tools (1)
- Drug safety (1)
- Drug screening (1)
- HDAC4 (1)
- Inflammation (1)
- MODY (1)
- Medicinal chemistry (1)
- Metabolic syndrome (1)
- NCoR1 (1)
- NR4A2 (1)
- NR4A3 (1)
- Orphan nuclear receptor (1)
- RXRα (1)
- Structural biology (1)
- Target identification (1)
- allostery (1)
- cofactor recruitment (1)
- differential scanning fluorimetry (1)
- drug discovery (1)
- drug target (1)
- fragment screening (1)
- fragment-based design (1)
- fragment-based drug design (1)
- hepatocyte nuclear factor 4α (1)
- heterodimer (1)
- homodimer (1)
- homogeneous time-resolved FRET (HTRF) (1)
- metabolic syndrome (1)
- montelukast (1)
- multitarget drugs (1)
- nuclear receptor-related 1 (1)
- pharmacophore model (1)
- pranlukast (1)
- retinoid X receptor (1)
- soluble epoxide hydrolase (1)
- stearic acid (1)
- type 2 diabetes (1)
- zafirlukast (1)
Institute
- Biochemie, Chemie und Pharmazie (7)
- Medizin (4)
- Pharmazie (3)
- Biochemie und Chemie (2)
The retinoid X receptor (RXR) is a ligand-sensing transcription factor acting mainly as a universal heterodimer partner for other nuclear receptors. Despite presenting as a potential therapeutic target for cancer and neurodegeneration, adverse effects typically observed for RXR agonists, likely due to the lack of isoform selectivity, limit chemotherapeutic application of currently available RXR ligands. The three human RXR isoforms exhibit different expression patterns; however, they share high sequence similarity, presenting a major obstacle toward the development of subtype-selective ligands. Here, we report the discovery of the saturated fatty acid, palmitic acid, as an RXR ligand and disclose a uniform set of crystal structures of all three RXR isoforms in an active conformation induced by palmitic acid. A structural comparison revealed subtle differences among the RXR subtypes. We also observed an ability of palmitic acid as well as myristic acid and stearic acid to induce recruitment of steroid receptor co-activator 1 to the RXR ligand-binding domain with low micromolar potencies. With the high, millimolar endogenous concentrations of these highly abundant lipids, our results suggest their potential involvement in RXR signaling.
Designed multitarget ligands are a popular approach to generating efficient and safe drugs, and fragment-based strategies have been postulated as a versatile avenue to discover multitarget ligand leads. To systematically probe the potential of fragment-based multiple ligand discovery, we have employed a large fragment library for comprehensive screening on five targets chosen from proteins for which multitarget ligands have been successfully developed previously (soluble epoxide hydrolase, leukotriene A4 hydrolase, 5-lipoxygenase, retinoid X receptor, farnesoid X receptor). Differential scanning fluorimetry served as primary screening method before fragments hitting at least two targets were validated in orthogonal assays. Thereby, we obtained valuable fragment leads with dual-target engagement for six out of ten target combinations. Our results demonstrate the applicability of fragment-based approaches to identify starting points for polypharmacological compound development with certain limitations.